Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies

Clinical Lymphoma, Myeloma and Leukemia

Volumn 10, Issue 4, 2010, Pages 278-280

  Wood, Prescilla B ^a   McElroy, Yolonda G ^a   Stone, Marvin J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amyloidosis; Monoclonal gammopathy; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; M PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTROPHORESIS; FREE LIGHT CHAIN ASSAY; HUMAN; IMMUNOFIXATION ELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; SCREENING; ANALYTIC METHOD; BLOOD SAMPLING; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; SENSITIVITY AND SPECIFICITY;

EID: 85047686096     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2010.n.057     Document Type: Article

References (15)

1. Stone MJ, Frenkel EP. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med 1975; 58:601-19.
2. Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001; 47:673-80.
3. Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002; 48:1437-44.
4. Bradwell AR. Serum free light chain analysis, 4th Ed., Birmingham, U.K., The Binding Site Ltd., 2006:14, 28, 47-50.
5. Katzmann JA, Abraham RS, Dispenzieri A, et al. Diagnostic performance of quantitative K and A free light chain assays in clinical practice. Clin Chem 2005; 51:878-81.
6. Katzmann JA, Dispenzieri A, Kyle RA, et al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc 2006; 81:1575-8.
7. Jagannath S. Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology. Clin Lymphoma Myeloma 2007; 7:518-23.
8. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005; 106:812-7.
9. Dispenzieri A, Zhang L, Katzmann JA, et al. Appraisal of immunoglobulin free light chain as a marker of response. Blood 2008; 111:4908-15.
10. Dispenzieri A, Kyle R, Merlini G, et al. International myeloma working group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009; 23:215-24.
11. Jaskowski TD, Litwin CM, Hill HR. Detection of K and A light chain monoclonal proteins in human serum: Automated immunoassay versus immunofixation electrophoresis. Clin Vaccine Immunol 2006; 13:277-80.
12. Shaheen SP, Levinson SS. Serum free light chain analysis may miss monoclonal light chains that urine immunofixation would detect. Clin Chim Acta 2009; 406:162-6.
13. Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113:5412-7.
14. Singhal S, Vickrey E, Krishnamurthy J, et al. The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios. Blood 2009; 114:38-9.
15. Katzmann JA, Kyle RA, Benson J, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem 2009; 55:1517-22.